Patents by Inventor Ron D. Carroll

Ron D. Carroll has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tetrandrine family pharmaceutical formulations and method
    Patent number: 10815243
    Abstract: Drug formulations, methods and their use in treatment of diseases using formulations of pure di-acid salts of tetrandrine family members, especially d-tetrandrine di-hydrochloride, combined with a pharmaceutical diluent or carrier.
    Type: Grant
    Filed: June 20, 2018
    Date of Patent: October 27, 2020
    Assignee: CBA Pharma, Inc.
    Inventor: Ron D. Carroll
  • TETRANDRINE FAMILY PHARMACEUTICAL FORMULATIONS AND METHOD
    Publication number: 20180298022
    Abstract: Drug formulations, methods and their use in treatment of diseases using formulations of pure di-acid salts of tetrandrine family members, especially d-tetrandrine di-hydrochloride, combined with a pharmaceutical diluent or carrier.
    Type: Application
    Filed: June 20, 2018
    Publication date: October 18, 2018
    Applicant: CBA Pharma, Inc.
    Inventor: Ron D. Carroll
  • Tetrandrine family pharmaceutical formulations and method
    Patent number: 10023584
    Abstract: Drug formulations, methods and their use in treatment of diseases using formulations of pure di-acid salts of tetrandrine family members, especially d-tetrandrine di-hydrochloride, combined with a pharmaceutical diluent or carrier.
    Type: Grant
    Filed: November 8, 2016
    Date of Patent: July 17, 2018
    Assignee: CBA Pharma, Inc.
    Inventor: Ron D. Carroll
  • TETRANDRINE FAMILY PHARMACEUTICAL FORMULATIONS AND METHOD
    Publication number: 20170050976
    Abstract: Drug formulations, methods and their use in treatment of diseases using formulations of pure di-acid salts of tetrandrine family members, especially d-tetrandrine di-hydrochloride, combined with a pharmaceutical diluent or carrier.
    Type: Application
    Filed: November 8, 2016
    Publication date: February 23, 2017
    Applicant: CBA Pharma, Inc.
    Inventor: Ron D. Carroll
  • TETRANDRINE FAMILY PHARMACEUTICAL FORMULATIONS AND METHOD
    Publication number: 20170050975
    Abstract: Drug formulations, methods and their use in treatment of diseases using formulations of pure di-acid salts of tetrandrine family members, especially d-tetrandrine di-hydrochloride, combined with a pharmaceutical diluent or carrier.
    Type: Application
    Filed: November 8, 2016
    Publication date: February 23, 2017
    Applicant: CBA Pharma, Inc.
    Inventor: Ron D. Carroll
  • Tetrandrine family pharmaceutical formulations and method
    Patent number: 9517234
    Abstract: Drug formulations, methods and their use in treatment of diseases using formulations of pure di-acid salts of tetrandrine family members, especially d-tetrandrine di-hydrochloride, combined with a pharmaceutical diluent or carrier.
    Type: Grant
    Filed: March 6, 2014
    Date of Patent: December 13, 2016
    Assignee: CBA Pharma, Inc.
    Inventor: Ron D. Carroll
  • Tetrandrine pharmaceutical formulations
    Patent number: 9259420
    Abstract: Drug formulations, methods and their use in treatment of diseases using the free base formulations of tetrandrine family members, especially d-tetrandrine, combined with a pharmaceutical diluent or carrier.
    Type: Grant
    Filed: September 12, 2013
    Date of Patent: February 16, 2016
    Assignee: CBA Pharma, Inc.
    Inventor: Ron D. Carroll
  • TETRANDRINE FAMILY PHARMACEUTICAL FORMULATIONS AND METHOD
    Publication number: 20140275137
    Abstract: Drug formulations, methods and their use in treatment of diseases using formulations of pure di-acid salts of tetrandrine family members, especially d-tetrandrine di-hydrochloride, combined with a pharmaceutical diluent or carrier.
    Type: Application
    Filed: March 6, 2014
    Publication date: September 18, 2014
    Applicant: CBA Pharma, Inc.
    Inventor: Ron D. Carroll
  • TETRANDRINE PHARMACEUTICAL FORMULATIONS AND METHOD
    Publication number: 20140135354
    Abstract: Drug formulations, methods and their use in treatment of diseases using the free base formulations of tetrandrine family members, especially d-tetrandrine, combined with a pharmaceutical diluent or carrier.
    Type: Application
    Filed: September 12, 2013
    Publication date: May 15, 2014
    Applicant: CBA Pharma, Inc.
    Inventor: Ron D. Carroll
  • Method for extracting and purifying bisbenzylisoquinolines
    Patent number: 8609844
    Abstract: A method for purifying extracted crude d-tetrandrine by dissolving the crude d-tetrandrine powder in ethanol, treating the solution with a decolorizing agent, filtering, reducing the filtered solution under heat and vacuum, cooling the solution, filtering it and drying the filtered cake to yield substantially pure d-tetrandrine.
    Type: Grant
    Filed: November 4, 2010
    Date of Patent: December 17, 2013
    Assignee: CBA Pharma, Inc.
    Inventor: Ron D. Carroll
  • METHOD FOR EXTRACTING AND PURIFYING BISBENZYLISOQUINOLINES
    Publication number: 20130231483
    Abstract: A method for purifying extracted crude d-tetrandrine by dissolving the crude d-tetrandrine powder in ethanol, treating the solution with a decolorizing agent, filtering, reducing the filtered solution under heat and vacuum, cooling the solution, filtering it and drying the filtered cake to yield substantially pure d-tetrandrine.
    Type: Application
    Filed: November 4, 2010
    Publication date: September 5, 2013
    Inventor: Ron D. Carroll
  • METHOD FOR EXTRACTING AND PURIFYING BISBENZYLISOQUINOLINES
    Publication number: 20110105755
    Abstract: A method for purifying extracted crude d-tetrandrine by dissolving the crude d-tetrandrine powder in ethanol, treating the solution with a decolorizing agent, filtering, reducing the filtered solution under heat and vacuum, cooling the solution, filtering it and drying the filtered cake to yield substantially pure d-tetrandrine.
    Type: Application
    Filed: November 4, 2010
    Publication date: May 5, 2011
    Inventor: Ron D. Carroll